Cargando…

A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR (-/-) Mice

BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease and a risk factor for cirrhosis, hepatocellular carcinoma and liver failure. Previously, we reported that dietary docosahexaenoic acid (DHA, 22:6,n-3) was more effective than eicosapentaenoic ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Depner, Christopher M., Traber, Maret G., Bobe, Gerd, Kensicki, Elizabeth, Bohren, Kurt M., Milne, Ginger, Jump, Donald B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866250/
https://www.ncbi.nlm.nih.gov/pubmed/24358308
http://dx.doi.org/10.1371/journal.pone.0083756
_version_ 1782296132924211200
author Depner, Christopher M.
Traber, Maret G.
Bobe, Gerd
Kensicki, Elizabeth
Bohren, Kurt M.
Milne, Ginger
Jump, Donald B.
author_facet Depner, Christopher M.
Traber, Maret G.
Bobe, Gerd
Kensicki, Elizabeth
Bohren, Kurt M.
Milne, Ginger
Jump, Donald B.
author_sort Depner, Christopher M.
collection PubMed
description BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease and a risk factor for cirrhosis, hepatocellular carcinoma and liver failure. Previously, we reported that dietary docosahexaenoic acid (DHA, 22:6,n-3) was more effective than eicosapentaenoic acid (EPA, 20:5,n-3) at reversing western diet (WD) induced NASH in LDLR(-/-) mice. METHODS: Using livers from our previous study, we carried out a global non-targeted metabolomic approach to quantify diet-induced changes in hepatic metabolism. RESULTS: Livers from WD + olive oil (WD + O)-fed mice displayed histological and gene expression features consistent with NASH. The metabolomic analysis of 320 metabolites established that the WD and n-3 polyunsaturated fatty acid (PUFA) supplementation had broad effects on all major metabolic pathways. Livers from WD + O-fed mice were enriched in saturated (SFA) and monounsaturated fatty acids (MUFA), palmitoyl-sphingomyelin, cholesterol, n-6 PUFA, n-6 PUFA-containing phosphoglycerolipids, n-6 PUFA-derived oxidized lipids (12-HETE) and depleted of C(20-22) n-3 PUFA-containing phosphoglycerolipids, C(20-22) n-3 PUFA-derived oxidized lipids (18-HEPE, 17,18-DiHETE) and S-lactoylglutathione, a methylglyoxal detoxification product. WD + DHA was more effective than WD + EPA at attenuating WD + O-induced changes in NASH gene expression markers, n-6 PUFA and oxidized lipids, citrate and S-lactosyl glutathione. Diet-induced changes in hepatic MUFA and sphingolipid content were associated with changes in expression of enzymes involved in MUFA and sphingolipid synthesis. Changes in hepatic oxidized fatty acids and S-lactoylglutathione, however, correlated with hepatic n-3 and n-6 C(20-22) PUFA content. Hepatic C(20-22) n-3 PUFA content was inversely associated with hepatic α-tocopherol and ascorbate content and positively associated with urinary F2- and F3-isoprostanes, revealing diet effects on whole body oxidative stress. CONCLUSION: DHA regulation of hepatic SFA, MUFA, PUFA, sphingomyelin, PUFA-derived oxidized lipids and S-lactoylglutathione may explain the protective effects of DHA against WD-induced NASH in LDLR(-/-) mice.
format Online
Article
Text
id pubmed-3866250
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38662502013-12-19 A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR (-/-) Mice Depner, Christopher M. Traber, Maret G. Bobe, Gerd Kensicki, Elizabeth Bohren, Kurt M. Milne, Ginger Jump, Donald B. PLoS One Research Article BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease and a risk factor for cirrhosis, hepatocellular carcinoma and liver failure. Previously, we reported that dietary docosahexaenoic acid (DHA, 22:6,n-3) was more effective than eicosapentaenoic acid (EPA, 20:5,n-3) at reversing western diet (WD) induced NASH in LDLR(-/-) mice. METHODS: Using livers from our previous study, we carried out a global non-targeted metabolomic approach to quantify diet-induced changes in hepatic metabolism. RESULTS: Livers from WD + olive oil (WD + O)-fed mice displayed histological and gene expression features consistent with NASH. The metabolomic analysis of 320 metabolites established that the WD and n-3 polyunsaturated fatty acid (PUFA) supplementation had broad effects on all major metabolic pathways. Livers from WD + O-fed mice were enriched in saturated (SFA) and monounsaturated fatty acids (MUFA), palmitoyl-sphingomyelin, cholesterol, n-6 PUFA, n-6 PUFA-containing phosphoglycerolipids, n-6 PUFA-derived oxidized lipids (12-HETE) and depleted of C(20-22) n-3 PUFA-containing phosphoglycerolipids, C(20-22) n-3 PUFA-derived oxidized lipids (18-HEPE, 17,18-DiHETE) and S-lactoylglutathione, a methylglyoxal detoxification product. WD + DHA was more effective than WD + EPA at attenuating WD + O-induced changes in NASH gene expression markers, n-6 PUFA and oxidized lipids, citrate and S-lactosyl glutathione. Diet-induced changes in hepatic MUFA and sphingolipid content were associated with changes in expression of enzymes involved in MUFA and sphingolipid synthesis. Changes in hepatic oxidized fatty acids and S-lactoylglutathione, however, correlated with hepatic n-3 and n-6 C(20-22) PUFA content. Hepatic C(20-22) n-3 PUFA content was inversely associated with hepatic α-tocopherol and ascorbate content and positively associated with urinary F2- and F3-isoprostanes, revealing diet effects on whole body oxidative stress. CONCLUSION: DHA regulation of hepatic SFA, MUFA, PUFA, sphingomyelin, PUFA-derived oxidized lipids and S-lactoylglutathione may explain the protective effects of DHA against WD-induced NASH in LDLR(-/-) mice. Public Library of Science 2013-12-17 /pmc/articles/PMC3866250/ /pubmed/24358308 http://dx.doi.org/10.1371/journal.pone.0083756 Text en © 2013 Depner et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Depner, Christopher M.
Traber, Maret G.
Bobe, Gerd
Kensicki, Elizabeth
Bohren, Kurt M.
Milne, Ginger
Jump, Donald B.
A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR (-/-) Mice
title A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR (-/-) Mice
title_full A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR (-/-) Mice
title_fullStr A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR (-/-) Mice
title_full_unstemmed A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR (-/-) Mice
title_short A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR (-/-) Mice
title_sort metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in ldlr (-/-) mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866250/
https://www.ncbi.nlm.nih.gov/pubmed/24358308
http://dx.doi.org/10.1371/journal.pone.0083756
work_keys_str_mv AT depnerchristopherm ametabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT trabermaretg ametabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT bobegerd ametabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT kensickielizabeth ametabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT bohrenkurtm ametabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT milneginger ametabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT jumpdonaldb ametabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT depnerchristopherm metabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT trabermaretg metabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT bobegerd metabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT kensickielizabeth metabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT bohrenkurtm metabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT milneginger metabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice
AT jumpdonaldb metabolomicanalysisofomega3fattyacidmediatedattenuationofwesterndietinducednonalcoholicsteatohepatitisinldlrmice